| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 02/14/2007 | EP1751167A1 Thienopyridine derivatives, production method and use thereof |
| 02/14/2007 | EP1751166A1 Mono-, oligo- and polythieno[3,2-b]thiophenes |
| 02/14/2007 | EP1751138A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
| 02/14/2007 | EP1751134A1 Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents |
| 02/14/2007 | EP1751130A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/14/2007 | EP1750701A1 Amorphous clopidogrel hydrochloride and its antithrombotic use |
| 02/14/2007 | EP1562944B1 Pyrazoloquinolines with immunomodulating activity |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | CN1914179A Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 02/14/2007 | CN1914172A 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911915A Lactam compound and medicinal use thereof |
| 02/14/2007 | CN1300144C Organic non-linear optical chromophore compound containing 1,3-dithio cyclopentenyl group |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/13/2007 | CA2254759C Inhibitors of prenyl transferases |
| 02/08/2007 | WO2007015866A2 Inhibitors of p38 kinase and methods of treating inflammatory disorders |
| 02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/08/2007 | US20070032528 inhibitors of vascular endothelial growth factor receptor tyrosine kinase; antiproliferative agents; antitumor; 4-Hydroxy-3-(5-methylbenzimidazol-2-yl)hydropyridino[3,4-b]pyridin-2-one; nitrogen containing cyclic compounds |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070032497 Fused-ring compounds and use thereof as drugs |
| 02/08/2007 | CA2616937A1 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 02/07/2007 | EP1749010A2 Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno 2, 3-b 1,5 benzodiazepine and salts thereof |
| 02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | EP0971748B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 02/07/2007 | CN1910190A Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group |
| 02/07/2007 | CN1907982A New compounds useful for the treatment of obesity,type II diabetes and CNS disorders |
| 02/07/2007 | CN1298705C Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 02/06/2007 | US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 02/06/2007 | US7173031 Pyrrolotriazine kinase inhibitors |
| 02/06/2007 | US7173029 Fused heteroaryl derivatives |
| 02/01/2007 | WO2006074919A3 3-AMINO-6-ARYL(OR 6-HETEROARYL)-THIENO[2,3-B]PYRIDIN-2-CARBOXAMIDES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND THEIR USE AS TNFα INHIBITORS |
| 02/01/2007 | US20070027317 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
| 01/31/2007 | EP1748044A1 Thiazole compound and use thereof |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | EP1746994A2 Thienopyridinone compounds and methods of treatment |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | CN1906201A Methods of preparing olanzapine |
| 01/31/2007 | CN1906173A Protein modifier production inhibitor |
| 01/31/2007 | CN1905884A Pyrazole derivatives as inhibitors of receptor tyrosyne kinases |
| 01/31/2007 | CN1905793A 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides |
| 01/31/2007 | CN1903859A Method of preparing chloropy gra hydrogen sulphate type I |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/30/2007 | US7169953 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 01/30/2007 | US7169922 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 01/30/2007 | US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/30/2007 | US7169558 Using non-radioactive markers to identify nascent proteins translated within cellular or cell-free translation systems; bioremediation and pollution contol of biohazards |
| 01/30/2007 | CA2289623C A new process for the preparation of a pharmacologically active substance |
| 01/30/2007 | CA2286723C Tricyclic compounds |
| 01/25/2007 | WO2007011811A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | WO2007011286A1 Therapeutic agents |
| 01/25/2007 | WO2007011285A1 Therapeutic agents |
| 01/25/2007 | WO2007011284A1 Therapeutic agents |
| 01/25/2007 | WO2007011072A1 Premature ovulation preventive agent |
| 01/25/2007 | WO2007009898A1 1h-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors |
| 01/25/2007 | WO2007009788A1 A process and composition for making olanzapine form (i) |
| 01/25/2007 | WO2007009687A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 01/25/2007 | WO2007009227A1 Hepatitis c inhibitor peptide analogs |
| 01/25/2007 | WO2006110654A8 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 01/25/2007 | US20070020643 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
| 01/25/2007 | US20070020176 Contrast agent |
| 01/25/2007 | CA2615795A1 Premature ovulation preventive agent |
| 01/24/2007 | EP1746100A1 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof |
| 01/24/2007 | EP1746096A1 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer |
| 01/24/2007 | EP1745051A1 Thienopyridazines as ikk inhibitors |
| 01/24/2007 | EP1745050A1 Thienopyridines as ikk inhibitors |
| 01/24/2007 | EP1745049A1 Derivatives of thienopyrrole as gnrh antagonists |
| 01/24/2007 | EP1745040A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 01/24/2007 | CN1902201A Bicyclic pyrimidin-4-(3H)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1) |
| 01/24/2007 | CN1902168A Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/23/2007 | CA2338311C Prodrugs of the pyridyl methyl sulfinyl benzimidazoles |
| 01/18/2007 | WO2007008895A1 Kinase inhibitors |
| 01/18/2007 | WO2007007625A1 Pharmaceutical for prevention of hypersensitivity |
| 01/18/2007 | WO2007006211A1 Dipeptidyl peptidase iv (ddp iv) inhibitors, preparation methods and uses thereof |
| 01/18/2007 | US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/18/2007 | US20070015746 Azepine derivaties as pharmaceutical agents |
| 01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
| 01/18/2007 | CA2612442A1 Heterotetracyclic compounds as tpo mimetics |
| 01/18/2007 | CA2602389A1 Kinase inhibitors |
| 01/17/2007 | EP1743888A1 Carbonyl substituted pyrazoline compounds, their preparation and use as CB1 receptor modulators |
| 01/17/2007 | EP1603914B1 Compounds having activity at 5ht2c receptor and uses thereof |
| 01/17/2007 | CN1898249A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 01/17/2007 | CN1896078A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |